JUL 17, 2018 11:30 PM PDT

Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR

A group of researchers are exploring a “trojan horse” tumor destruction model using the main tumor’s own cells.  They published their ideas and outcomes in the July 11, 2018 issue of Science Translational Medicine

Cancerous tumors are comprised of tumor cells that are dividing uncontrollably.  Some tumor cells will drift out into circulation and return to the main tumor site via a built in “homing” mechanism.  Researchers at Harvard have duped these roaming tumor cells into delivering cancer therapies directly to their main tumor, thereby initiating destruction of the main tumor.  Sounds like an in-body sci-fi experience written for a new fiction novel.

New gene editing technology, namely use of CRISPR-Cas9, is how this is actually possible.  Gene editing is the ability to change an organism’s physical DNA.  New sequences or genes can be added, removed, or modified within the genome.  CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9.  Bacteria use a similar genome editing mechanism naturally which is why bacteria have been primarily been used as vectors for genome editing up until very recently.  DNA is cut into small fragments and incorporated into a CRISPR locus so that when this is transcribed, the small RNAs have a new target which is then cut by the Cas9 enzyme.  In this study, the authors removed tumor cells and using CRISPR, created the expression of a death receptor on these tumor cells which causes cells to enter apoptosis.  These engineered tumor cells also included a mechanism whereby interaction with a particular drug would induce apoptosis of the engineered “trojan horse” tumor cell before it repopulated the main tumor site following loss of main tumor bulk or went on to start new tumor sites in the body. 

The study used mouse models with primary glioblastoma, recurrent glioblastoma, and breast cancer.  The therapeutic approach had discernable benefits for survival in mice; tumors were considerably reduced in size and reported that 90 percent of mice had increased survival weeks and months following the treatment intervention compared to the control mice (untreated) of which nearly 100 percent died within that same timeframe. 

There are still many unanswered questions surrounding this approach that need further investigation but the potential for using this particular unique “homing” feature of tumor cells is undeniable. 

Sources: Science Translational Medicine, NIH Genetics Home Reference, New England BioLabs, Scientific American,

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 05, 2018
Cancer
JUN 05, 2018
Clinical Trial Evaluates Precision Medicine Approaches for Common and Rare Cancers
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles determined through molecular diagnostic testing....
JUN 13, 2018
Cancer
JUN 13, 2018
Tailored vaccine boosts survival for some brain cancer patients
In a new multicenter clinical trial, a personalized vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma. Currently...
AUG 07, 2018
Cancer
AUG 07, 2018
Is There a Best Time of Day to Administer Chemo?
A common hematologic cancer chemotherapy agent is looked at for its efficacy on solid tumors and specifically evaluates if delivery time during the day affects is anti-tumor activity....
AUG 07, 2018
Cancer
AUG 07, 2018
Can a Myeloid Marker Be Helpful in B-cell Neoplasm Diagnostic Testing?
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detailed diagnosis....
AUG 21, 2018
Health & Medicine
AUG 21, 2018
First, They Came for the Straws...Now the Soda?
Bans on plastic straws and utensils are all over the news recently. While taking care of the planet is crucial, some critics say that banning plastic straw...
OCT 04, 2018
Videos
OCT 04, 2018
Zebrafish as Metastatic Cancer Model
Another Koch Institute Image Award winner from 2018 is presented in this video from MIT....
Loading Comments...